180 related articles for article (PubMed ID: 26684358)
1. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
[TBL] [Abstract][Full Text] [Related]
2. Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer.
Li Y; Tian Z; Tan Y; Lian G; Chen S; Chen S; Li J; Li X; Huang K; Chen Y
Mol Cancer; 2020 Jun; 19(1):109. PubMed ID: 32580736
[TBL] [Abstract][Full Text] [Related]
3. miR-491-5p, mediated by Foxi1, functions as a tumor suppressor by targeting Wnt3a/β-catenin signaling in the development of gastric cancer.
Sun R; Liu Z; Tong D; Yang Y; Guo B; Wang X; Zhao L; Huang C
Cell Death Dis; 2017 Mar; 8(3):e2714. PubMed ID: 28358374
[TBL] [Abstract][Full Text] [Related]
4. FoxP3-miR-150-5p/3p suppresses ovarian tumorigenesis via an IGF1R/IRS1 pathway feedback loop.
Zhang Q; Zhou X; Wan M; Zeng X; Luo J; Xu Y; Ji L; Zhang JA; Fan P; Zhong J; Wu J
Cell Death Dis; 2021 Mar; 12(3):275. PubMed ID: 33723215
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia downregulated miR-4521 suppresses gastric carcinoma progression through regulation of IGF2 and FOXM1.
Xing S; Tian Z; Zheng W; Yang W; Du N; Gu Y; Yin J; Liu H; Jia X; Huang D; Liu W; Deng M
Mol Cancer; 2021 Jan; 20(1):9. PubMed ID: 33407516
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway.
Zhang X; Ke X; Pu Q; Yuan Y; Yang W; Luo X; Jiang Q; Hu X; Gong Y; Tang K; Su X; Liu L; Zhu W; Wei Y
Oncotarget; 2016 Mar; 7(12):14569-85. PubMed ID: 26910912
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-139-5p Inhibits Cell Proliferation and Invasion by Targeting RHO-Associated Coiled-Coil-Containing Protein Kinase 2 in Ovarian Cancer.
Wang Y; Li J; Xu C; Zhang X
Oncol Res; 2018 Apr; 26(3):411-420. PubMed ID: 28653604
[TBL] [Abstract][Full Text] [Related]
8. miR-885-5p Inhibits Invasion and Metastasis in Gastric Cancer by Targeting Malic Enzyme 1.
Jiang Z; Cui H; Zeng S; Li L
DNA Cell Biol; 2021 May; 40(5):694-705. PubMed ID: 33751897
[TBL] [Abstract][Full Text] [Related]
9. miR-125a-5p promotes gastric cancer growth and invasion by regulating the Hippo pathway.
Li R; Hu Z; Wang Z; Zhu T; Wang G; Gao B; Wang J; Deng X
J Clin Lab Anal; 2021 Dec; 35(12):e24078. PubMed ID: 34708891
[TBL] [Abstract][Full Text] [Related]
10. miR-33a-5p inhibits the progression of esophageal cancer through the DKK1-mediated Wnt/β-catenin pathway.
Song Q; Liu H; Li C; Liang H
Aging (Albany NY); 2021 Aug; 13(16):20481-20494. PubMed ID: 34426559
[TBL] [Abstract][Full Text] [Related]
11. Formononetin exhibits anticancer activity in gastric carcinoma cell and regulating miR-542-5p.
Wang WS; Zhao CS
Kaohsiung J Med Sci; 2021 Mar; 37(3):215-225. PubMed ID: 33231363
[TBL] [Abstract][Full Text] [Related]
12. Exosomal miR-106a derived from gastric cancer promotes peritoneal metastasis via direct regulation of Smad7.
Zhu M; Zhang N; He S; Lu X
Cell Cycle; 2020 May; 19(10):1200-1221. PubMed ID: 32267797
[TBL] [Abstract][Full Text] [Related]
13. MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway.
Zhou W; Li Y; Gou S; Xiong J; Wu H; Wang C; Yan H; Liu T
Oncotarget; 2015 Nov; 6(35):37557-69. PubMed ID: 26485754
[TBL] [Abstract][Full Text] [Related]
14. MiR-216b regulates the tumorigenesis of gastric cancer by targeting PXN.
Liu X; Xu D; Xu X; Xue Q; Gao X; Tang C
Pathol Res Pract; 2021 Feb; 218():153325. PubMed ID: 33422779
[TBL] [Abstract][Full Text] [Related]
15. microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2.
Min J; Han TS; Sohn Y; Shimizu T; Choi B; Bae SW; Hur K; Kong SH; Suh YS; Lee HJ; Kim JS; Min JK; Kim WH; Kim VN; Choi E; Goldenring JR; Yang HK
Gastric Cancer; 2020 Jul; 23(4):600-613. PubMed ID: 32112274
[TBL] [Abstract][Full Text] [Related]
16. NOVA1 inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal.
Yoon SO; Kim EK; Lee M; Jung WY; Lee H; Kang Y; Jang YJ; Hong SW; Choi SH; Yang WI
Oncotarget; 2016 Jan; 7(3):2475-95. PubMed ID: 26673617
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-647 Targets SRF-MYH9 Axis to Suppress Invasion and Metastasis of Gastric Cancer.
Ye G; Huang K; Yu J; Zhao L; Zhu X; Yang Q; Li W; Jiang Y; Zhuang B; Liu H; Shen Z; Wang D; Yan L; Zhang L; Zhou H; Hu Y; Deng H; Liu H; Li G; Qi X
Theranostics; 2017; 7(13):3338-3353. PubMed ID: 28900514
[TBL] [Abstract][Full Text] [Related]
18. MiR-507 inhibits the progression of gastric carcinoma via targeting CBX4-mediated activation of Wnt/β-catenin and HIF-1α pathways.
Fang X; Pan A
Clin Transl Oncol; 2022 Oct; 24(10):2021-2028. PubMed ID: 35819589
[TBL] [Abstract][Full Text] [Related]
19. Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis.
Ye G; Yang Q; Lei X; Zhu X; Li F; He J; Chen H; Ling R; Zhang H; Lin T; Liang Z; Liang Y; Huang H; Guo W; Deng H; Liu H; Hu Y; Yu J; Li G
Theranostics; 2020; 10(17):7545-7560. PubMed ID: 32685004
[No Abstract] [Full Text] [Related]
20. SIK2 represses AKT/GSK3β/β-catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases.
Dai XM; Zhang YH; Lin XH; Huang XX; Zhang Y; Xue CR; Chen WN; Ye JX; Lin XJ; Lin X
Mol Oncol; 2021 Jan; 15(1):228-245. PubMed ID: 33128264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
